Changeflow GovPing Government General Minnesota SF4419 Prescription Drug Provisions
Priority review Consultation Amended Draft

Minnesota SF4419 Prescription Drug Provisions

Favicon for changeflow.com Minnesota Legislative Events
Published
Detected
Email

Summary

The Minnesota Senate passed SF4419 on March 12, 2026, modifying various prescription drug transaction, coverage, and data provisions. The bill, sponsored by Sen. Melissa Wiklund, was amended and re-referred to the Health and Human Services Committee.

Healthcare providers, insurers, and pharmaceutical companies operating in Minnesota should monitor the bill as it progresses through remaining legislative stages, including potential House action and gubernatorial consideration, since further amendments could occur before final enactment.

Published by MN Senate on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

The Minnesota Senate passed SF4419, a bill amending various prescription drug transaction, coverage, and data provisions under Minnesota state law. The bill was introduced on March 11, 2026, received committee referrals to Health and Human Services and Commerce and Consumer Protection, and passed the Senate as amended on March 12, 2026.

Affected parties in Minnesota's healthcare and pharmaceutical sectors — including providers, insurers, and drug manufacturers — should monitor the bill's continued progress through the legislative process, as further amendments may occur before final enactment and any compliance obligations are crystallized.

Archived snapshot

Apr 22, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

ChangeBridge / Minnesota / SF4419 Passed SF4419 SF Passed 2026-03-12

Various prescription drug transaction, coverage, and data provisions modifications

Bill Details

State Minnesota

Session 94th Legislature 2025-2026

Chamber Senate

Committee Health and Human Services

Official Source www.revisor.mn.gov/bills/94/2026/0/SF/4419/

LegiScan View on LegiScan

Sponsors

Melissa Wiklund (Sen - D)

Action History

2026-04-07 S Comm report: To pass as amended and re-refer to Health and Human Services 2026-03-23 S Comm report: To pass as amended and re-refer to Commerce and Consumer Protection 2026-03-12 S Referred to Health and Human Services 2026-03-12 S Introduction and first reading

Committee Referrals

2026-03-12 S Health and Human Services 2026-03-23 S Commerce and Consumer Protection 2026-04-07 S Health and Human Services

Bill Text Versions

2026-03-11 Introduced 2026-03-23 Engrossed 2026-04-07 Engrossed Legislative data powered by LegiScan (CC BY 4.0)

Get daily alerts for Minnesota Legislative Events

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from MN Senate.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
MN Senate
Published
March 12th, 2026
Instrument
Consultation
Branch
Legislative
Bill ID
SF4419
Legal weight
Non-binding
Stage
Draft
Change scope
Substantive

Who this affects

Applies to
Healthcare providers Insurers Pharmaceutical companies
Industry sector
3254 Pharmaceutical Manufacturing
Activity scope
Prescription drug coverage Drug transaction rules Healthcare data provisions
Geographic scope
US-MN US-MN

Taxonomy

Primary area
Pharmaceuticals
Operational domain
Regulatory Affairs
Topics
Healthcare Insurance

Get alerts for this source

We'll email you when Minnesota Legislative Events publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!